Berry Global - 10-Q quarterly report FY2022 Q2

false10-022022Q20001378992http://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAssethttp://fasb.org/us-gaap/2021-01-31#OperatingLeaseRightOfUseAssethttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrenthttp://fasb.org/us-gaap/2021-01-31#OperatingLeaseLiabilityNoncurrenthttp://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNethttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationsCurrenthttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligationshttp://fasb.org/us-gaap/2021-01-31#LongTermDebtAndCapitalLeaseObligations2026-07-312024-05-312024-02-292025-07-312026-01-312026-07-312027-01-312027-07-312026-02-282027-07-3100013789922021-10-032022-04-0200013789922022-05-0500013789922021-01-032021-04-0300013789922020-09-272021-04-0300013789922022-01-022022-04-0200013789922021-10-0200013789922022-04-020001378992us-gaap:AdditionalPaidInCapitalMember2020-09-260001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-020001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-020001378992us-gaap:RetainedEarningsMember2020-09-260001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-260001378992us-gaap:CommonStockMember2021-10-020001378992us-gaap:AdditionalPaidInCapitalMember2022-01-0100013789922022-01-010001378992us-gaap:CommonStockMember2020-09-260001378992us-gaap:CommonStockMember2021-01-020001378992us-gaap:AdditionalPaidInCapitalMember2021-10-0200013789922021-01-020001378992us-gaap:RetainedEarningsMember2021-01-0200013789922020-09-260001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-010001378992us-gaap:RetainedEarningsMember2021-10-020001378992us-gaap:CommonStockMember2022-01-010001378992us-gaap:RetainedEarningsMember2022-01-010001378992us-gaap:AdditionalPaidInCapitalMember2021-01-020001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-032022-04-020001378992us-gaap:CommonStockMember2020-09-272021-04-030001378992us-gaap:RetainedEarningsMember2022-01-022022-04-020001378992us-gaap:AdditionalPaidInCapitalMember2022-01-022022-04-020001378992us-gaap:RetainedEarningsMember2021-01-032021-04-030001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-032021-04-030001378992us-gaap:RetainedEarningsMember2020-09-272021-04-030001378992us-gaap:AdditionalPaidInCapitalMember2021-10-032022-04-020001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-272021-04-030001378992us-gaap:CommonStockMember2021-10-032022-04-020001378992us-gaap:AdditionalPaidInCapitalMember2020-09-272021-04-030001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-022022-04-020001378992us-gaap:AdditionalPaidInCapitalMember2021-01-032021-04-030001378992us-gaap:RetainedEarningsMember2021-10-032022-04-020001378992us-gaap:CommonStockMember2022-01-022022-04-020001378992us-gaap:CommonStockMember2021-01-032021-04-030001378992us-gaap:RetainedEarningsMember2022-04-020001378992us-gaap:AdditionalPaidInCapitalMember2021-04-030001378992us-gaap:RetainedEarningsMember2021-04-030001378992us-gaap:CommonStockMember2022-04-0200013789922021-04-030001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-030001378992us-gaap:AdditionalPaidInCapitalMember2022-04-020001378992us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-020001378992us-gaap:CommonStockMember2021-04-030001378992bery:RotoMoldingBusinessMember2022-04-020001378992bery:RotoMoldingBusinessMember2020-10-032021-10-020001378992bery:RotoMoldingBusinessMemberus-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-04-020001378992bery:RotoMoldingBusinessMemberus-gaap:OtherCurrentLiabilitiesMember2022-04-020001378992bery:ConsumerPackagingInternationalMember2022-01-022022-04-020001378992bery:ConsumerPackagingNorthAmericaMember2020-09-272021-04-030001378992bery:EngineeredMaterialsMember2020-09-272021-04-030001378992bery:ConsumerPackagingInternationalMember2021-10-032022-04-020001378992bery:ConsumerPackagingNorthAmericaMember2021-01-032021-04-030001378992bery:EngineeredMaterialsMember2021-10-032022-04-020001378992bery:HealthHygieneAndSpecialtiesMember2021-01-032021-04-030001378992bery:ConsumerPackagingNorthAmericaMember2021-10-032022-04-020001378992bery:HealthHygieneAndSpecialtiesMember2020-09-272021-04-030001378992bery:ConsumerPackagingInternationalMember2020-09-272021-04-030001378992bery:ConsumerPackagingInternationalMember2021-01-032021-04-030001378992bery:EngineeredMaterialsMember2021-01-032021-04-030001378992bery:EngineeredMaterialsMember2022-01-022022-04-020001378992bery:HealthHygieneAndSpecialtiesMember2022-01-022022-04-020001378992bery:ConsumerPackagingNorthAmericaMember2022-01-022022-04-020001378992bery:HealthHygieneAndSpecialtiesMember2021-10-032022-04-020001378992us-gaap:EmployeeSeveranceMember2021-10-020001378992us-gaap:FacilityClosingMember2021-10-020001378992bery:TransactionActivitiesMember2021-10-020001378992us-gaap:FacilityClosingMember2021-10-032022-04-020001378992us-gaap:EmployeeSeveranceMember2021-10-032022-04-020001378992bery:TransactionActivitiesMember2021-10-032022-04-020001378992bery:TransactionActivitiesMember2022-04-020001378992us-gaap:EmployeeSeveranceMember2022-04-020001378992us-gaap:FacilityClosingMember2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJuly2026Member2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJanuary2027Member2021-10-020001378992bery:FinanceLeasesAndOtherMember2021-10-020001378992bery:SecondPrioritySeniorSecuredNotesDueFebruary2026Member2021-10-020001378992bery:SecondPrioritySeniorSecuredNotesDueJuly2027Member2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJuly2026Member2021-10-020001378992bery:TermLoanDueJuly2026Member2021-10-020001378992bery:TermLoanDueJuly2026Member2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesEuroDenominatedDueJuly2025Member2021-10-020001378992bery:FirstPrioritySeniorSecuredNotesEuroDenominatedDueJuly2027Member2021-10-020001378992bery:FinanceLeasesAndOtherMember2022-04-020001378992bery:SecondPrioritySeniorSecuredNotesDueFebruary2026Member2022-04-020001378992bery:SecondPrioritySeniorSecuredNotesDueJuly2027Member2021-10-020001378992bery:FirstPrioritySeniorSecuredNotesDueJanuary2027Member2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesEuroDenominatedDueJuly2027Member2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJanuary2026Member2021-10-020001378992bery:FirstPrioritySeniorSecuredNotesDueFebruary2024Member2021-10-020001378992bery:FirstPrioritySeniorSecuredNotesEuroDenominatedDueJuly2025Member2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJanuary2026Member2022-04-020001378992bery:RevolvingLineOfCreditMember2021-10-020001378992bery:RevolvingLineOfCreditMember2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueFebruary2024Member2022-04-020001378992bery:FirstPrioritySeniorSecuredNotesEuroDenominatedDueJuly2027Member2021-10-032022-04-020001378992bery:SecondPrioritySeniorSecuredNotesDueFebruary2026Member2021-10-032022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJuly2026Member2021-10-032022-04-020001378992bery:SecondPrioritySeniorSecuredNotesDueJuly2027Member2021-10-032022-04-020001378992bery:RevolvingLineOfCreditMember2021-10-032022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueFebruary2024Member2021-10-032022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJanuary2026Member2021-10-032022-04-020001378992bery:FirstPrioritySeniorSecuredNotesEuroDenominatedDueJuly2025Member2021-10-032022-04-020001378992bery:FirstPrioritySeniorSecuredNotesDueJanuary2027Member2021-10-032022-04-020001378992bery:TermLoanDueJuly2026Member2021-10-032022-04-020001378992bery:CrossCurrencyInterestRateContractMaturingMay2022Member2022-04-020001378992bery:CrossCurrencyInterestRateContract1MaturingJune2024Member2022-04-020001378992bery:CrossCurrencyInterestRateContract2MaturingJuly2027Member2022-04-020001378992bery:LongTermDebtEuroDenominatedMember2022-04-020001378992bery:InterestRateSwap2ExpiringJune2024Member2022-04-020001378992bery:InterestRateSwap1ExpiringJune2026Member2022-04-020001378992bery:InterestRateSwap3ExpiringJune2026Member2022-04-020001378992bery:InterestRateSwap1ExpiringJune2024Member2022-04-020001378992bery:InterestRateSwap2ExpiringJune2024Memberus-gaap:LondonInterbankOfferedRateLIBORMember2021-10-032022-04-020001378992bery:InterestRateSwap3ExpiringJune2026Memberus-gaap:LondonInterbankOfferedRateLIBORMember2021-10-032022-04-020001378992us-gaap:LondonInterbankOfferedRateLIBORMemberbery:InterestRateSwap1ExpiringJune2026Member2021-10-032022-04-020001378992bery:InterestRateSwap1ExpiringJune2024Memberus-gaap:LondonInterbankOfferedRateLIBORMember2021-10-032022-04-020001378992us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-10-020001378992us-gaap:NondesignatedMemberus-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2021-10-020001378992us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2022-04-020001378992us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMember2022-04-020001378992us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-10-020001378992us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CrossCurrencyInterestRateContractMemberus-gaap:OtherNoncurrentLiabilitiesMember2021-10-020001378992us-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMember2021-10-020001378992us-gaap:OtherNoncurrentAssetsMemberus-gaap:NondesignatedMemberus-gaap:InterestRateSwapMember2022-04-020001378992us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:InterestRateSwapMemberus-gaap:OtherNoncurrentAssetsMember2022-04-020001378992us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNoncurrentLiabilitiesMember2022-04-020001378992us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:InterestExpenseMember2021-01-032021-04-030001378992us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2020-09-272021-04-030001378992us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2021-10-032022-04-020001378992us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:InterestExpenseMember2021-10-032022-04-020001378992us-gaap:InterestExpenseMemberus-gaap:InterestRateSwapMember2021-01-032021-04-030001378992us-gaap:InterestRateSwapMemberus-gaap:InterestExpenseMember2022-01-022022-04-020001378992us-gaap:CrossCurrencyInterestRateContractMemberus-gaap:InterestExpenseMember2020-09-272021-04-030001378992us-gaap:InterestExpenseMemberus-gaap:CrossCurrencyInterestRateContractMember2022-01-022022-04-020001378992us-gaap:FairValueMeasurementsNonrecurringMember2022-04-020001378992us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel1Member2021-10-020001378992us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-04-020001378992us-gaap:FairValueMeasurementsNonrecurringMember2021-10-020001378992us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsNonrecurringMember2022-04-020001378992us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel3Member2022-04-020001378992us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2021-10-020001378992us-gaap:FairValueMeasurementsNonrecurringMemberus-gaap:FairValueInputsLevel2Member2021-10-0200013789922020-10-032021-10-020001378992bery:HealthHygieneAndSpecialtiesMemberus-gaap:OperatingSegmentsMember2020-09-272021-04-030001378992us-gaap:OperatingSegmentsMemberbery:ConsumerPackagingInternationalMember2021-01-032021-04-030001378992bery:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2020-09-272021-04-030001378992bery:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2021-10-032022-04-020001378992us-gaap:OperatingSegmentsMemberbery:ConsumerPackagingInternationalMember2020-09-272021-04-030001378992us-gaap:OperatingSegmentsMemberbery:HealthHygieneAndSpecialtiesMember2021-10-032022-04-020001378992us-gaap:OperatingSegmentsMemberbery:ConsumerPackagingNorthAmericaMember2021-10-032022-04-020001378992us-gaap:OperatingSegmentsMemberbery:HealthHygieneAndSpecialtiesMember2021-01-032021-04-030001378992bery:ConsumerPackagingNorthAmericaMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001378992bery:ConsumerPackagingNorthAmericaMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001378992us-gaap:OperatingSegmentsMemberbery:ConsumerPackagingInternationalMember2021-10-032022-04-020001378992us-gaap:OperatingSegmentsMemberbery:HealthHygieneAndSpecialtiesMember2022-01-022022-04-020001378992bery:ConsumerPackagingInternationalMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001378992bery:ConsumerPackagingNorthAmericaMemberus-gaap:OperatingSegmentsMember2020-09-272021-04-030001378992bery:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2021-01-032021-04-030001378992bery:EngineeredMaterialsMemberus-gaap:OperatingSegmentsMember2022-01-022022-04-020001378992bery:RestOfWorldMembersrt:ReportableGeographicalComponentsMember2020-09-272021-04-030001378992srt:ReportableGeographicalComponentsMembersrt:EuropeMember2022-01-022022-04-020001378992srt:ReportableGeographicalComponentsMemberbery:UnitedStatesAndCanadaMember2021-01-032021-04-030001378992bery:RestOfWorldMembersrt:ReportableGeographicalComponentsMember2021-10-032022-04-020001378992srt:EuropeMembersrt:ReportableGeographicalComponentsMember2021-01-032021-04-030001378992bery:RestOfWorldMembersrt:ReportableGeographicalComponentsMember2021-01-032021-04-030001378992srt:EuropeMembersrt:ReportableGeographicalComponentsMember2021-10-032022-04-020001378992bery:UnitedStatesAndCanadaMembersrt:ReportableGeographicalComponentsMember2021-10-032022-04-020001378992bery:UnitedStatesAndCanadaMembersrt:ReportableGeographicalComponentsMember2022-01-022022-04-020001378992srt:ReportableGeographicalComponentsMemberbery:RestOfWorldMember2022-01-022022-04-020001378992srt:ReportableGeographicalComponentsMembersrt:EuropeMember2020-09-272021-04-030001378992bery:UnitedStatesAndCanadaMembersrt:ReportableGeographicalComponentsMember2020-09-272021-04-030001378992bery:ShareRepurchaseProgram2022Member2022-01-022022-04-020001378992bery:ShareRepurchaseProgram2022Member2021-10-032022-04-020001378992bery:ShareRepurchaseProgram2022Member2022-04-020001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-010001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-020001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-10-020001378992us-gaap:AccumulatedTranslationAdjustmentMember2020-09-260001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-020001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-09-260001378992us-gaap:AccumulatedTranslationAdjustmentMember2021-10-020001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-010001378992us-gaap:AccumulatedTranslationAdjustmentMember2022-01-010001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-10-020001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-260001378992us-gaap:AccumulatedTranslationAdjustmentMember2021-01-020001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-01-032021-04-030001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-01-022022-04-020001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-10-032022-04-020001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-10-032022-04-020001378992us-gaap:AccumulatedTranslationAdjustmentMember2020-09-272021-04-030001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-09-272021-04-030001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-01-032021-04-030001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-272021-04-030001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-01-022022-04-020001378992us-gaap:AccumulatedTranslationAdjustmentMember2021-01-032021-04-030001378992us-gaap:AccumulatedTranslationAdjustmentMember2022-01-022022-04-020001378992us-gaap:AccumulatedTranslationAdjustmentMember2021-10-032022-04-020001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-04-020001378992us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-04-030001378992us-gaap:AccumulatedTranslationAdjustmentMember2022-04-020001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2021-04-030001378992us-gaap:AccumulatedTranslationAdjustmentMember2021-04-030001378992us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-04-02xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:EURiso4217:GBPbery:Segment

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 2, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 001-35672

BERRY GLOBAL GROUP, INC.

A Delaware corporation

101 Oakley Street, Evansville, Indiana, 47710

(812) 424-2904

IRS employer identification number

20-5234618

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	BERY	New York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ☒

Accelerated Filer ☐

Non-Accelerated Filer ☐

Smaller Reporting Company ☐

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

There were 130.3 million shares of common stock outstanding at May 5, 2022.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

Information included or incorporated by reference in Berry Global Group, Inc.’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contains or may contain forward-looking statements. This report includes “forward-looking” statements with respect to our financial condition, results of operations and business and our expectations or beliefs concerning future events. These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “project,” “outlook,” “anticipates” or “looking forward” or similar expressions that relate to our strategy, plans, intentions, or expectations. All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements. In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments. These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected. All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Additionally, we caution readers that the list of important factors discussed in our most recent Form 10-K in the section titled “Risk Factors” may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this report may not in fact occur. Accordingly, readers should not place undue reliance on those statements.

Berry Global Group, Inc.

Form 10-Q Index

For Quarterly Period Ended April 2, 2022

Part I.	Financial Information		Page No.
	Item 1.	Financial Statements:
		Consolidated Statements of Income and Comprehensive Income	4
		Consolidated Balance Sheets	5
		Consolidated Statements of Changes in Stockholders’ Equity	6
		Consolidated Statements of Cash Flows	7
		Notes to Consolidated Financial Statements	8
	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
	Item 3.	Quantitative and Qualitative Disclosures about Market Risk	22
	Item 4.	Controls and Procedures	23
Part II.	Other Information
	Item 1.	Legal Proceedings	24
	Item 1A.	Risk Factors	24
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	24
	Item 6.	Exhibits	25
	Signature		26

Index

Part I. Financial Information

Item 1.

Financial Statements

Berry Global Group, Inc.

Consolidated Statements of Income

(Unaudited)

(in millions of dollars, except per share amounts)

	Quarterly Period Ended				Two Quarterly Periods Ended
	April 2, 2022		April 3, 2021		April 2, 2022		April 3, 2021
Net sales	$	3,775	$	3,370	$	7,348	$	6,506
Costs and expenses:
Cost of goods sold		3,154		2,706		6,192		5,224
Selling, general and administrative		207		220		442		461
Amortization of intangibles		65		73		133		147
Restructuring and transaction activities		8		38		11		37
Operating income		341		333		570		637
Other expense		6		6		6		31
Interest expense		71		84		142		181
Income before income taxes		264		243		422		425
Income tax expense		59		62		96		114
Net income	$	205	$	181	$	326	$	311

Net income per share:
Basic	$	1.53	$	1.35	$	2.42	$	2.32
Diluted		1.50		1.32		2.36		2.28

Consolidated Statements of Comprehensive Income

(Unaudited)

(in millions of dollars)

	Quarterly Period Ended					Two Quarterly Periods Ended
	April 2, 2022		April 3, 2021			April 2, 2022		April 3, 2021
Net income	$	205	$	181		$	326	$	311
Other comprehensive income, net of tax:
Currency translation		37		(73	)		15		105
Derivative instruments		71		54			100		71
Other comprehensive income (loss)		108		(19	)		115		176
Comprehensive income	$	313	$	162		$	441	$	487

See notes to consolidated financial statements.

Index

Berry Global Group, Inc.

Consolidated Balance Sheets

(in millions of dollars)

	April 2, 2022			October 2, 2021
	(Unaudited)
Assets
Current assets:
Cash and cash equivalents	$	622		$	1,091
Accounts receivable		1,996			1,879
Finished goods		1,032			960
Raw materials and supplies		932			947
Prepaid expenses and other current assets		401			217
Total current assets		4,983			5,094
Noncurrent assets:
Property, plant and equipment		4,650			4,677
Goodwill and intangible assets		7,183			7,434
Right-of-use assets		536			562
Other assets		183			115
Total assets	$	17,535		$	17,882


Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	1,651		$	2,041
Accrued employee costs		250			336
Other current liabilities		824			788
Current portion of long-term debt		19			21
Total current liabilities		2,744			3,186
Noncurrent liabilities:
Long-term debt		9,627			9,439
Deferred income taxes		569			568
Employee benefit obligations		244			276
Operating lease liabilities		443			466
Other long-term liabilities		588			767
Total liabilities		14,215			14,702

Stockholders’ equity:
Common stock (130.4and 135.5 million shares issued, respectively)		1			1
Additional paid-in capital		1,174			1,134
Retained earnings		2,326			2,341
Accumulated other comprehensive loss		(181	)		(296	)
Total stockholders’ equity		3,320			3,180
Total liabilities and stockholders’ equity	$	17,535		$	17,882

See notes to consolidated financial statements.

Index

Berry Global Group, Inc.

Consolidated Statements of Changes in Stockholders’ Equity

(Unaudited)

(in millions of dollars)

Quarterly Period Ended	Common Stock		Additional Paid-in Capital			Accumulated Other Comprehensive Loss			Retained Earnings			Total
Balance at January 1, 2022	$	1	$	1,170		$	(289	)	$	2,412		$	3,294
Net income		—		—			—			205			205
Other comprehensive income		—		—			108			—			108
Share-based compensation		—		7			—			—			7
Proceeds from issuance of common stock		—		6			—			—			6
Common stock repurchased and retired		—		(9	)		—			(291	)		(300	)
Balance at April 2, 2022	$	1	$	1,174		$	(181	)	$	2,326		$	3,320

Balance at January 2, 2021	$	1	$	1,062		$	(356	)	$	1,738		$	2,445
Net income		—		—			—			181			181
Other comprehensive loss		—		—			(19	)		—			(19	)
Share-based compensation		—		7			—			—			7
Proceeds from issuance of common stock		—		32			—			—			32
Balance at April 3, 2021	$	1	$	1,101		$	(375	)	$	1,919		$	2,646

Two Quarterly Periods Ended	Common Stock		Additional Paid-in Capital			Accumulated Other Comprehensive Loss			Retained Earnings			Total
Balance at October 2, 2021	$	1	$	1,134		$	(296	)	$	2,341		$	3,180
Net income		—		—			—			326			326
Other comprehensive income		—		—			115			—			115
Share-based compensation		—		28			—			—			28
Proceeds from issuance of common stock		—		22			—			—			22
Common stock repurchased and retired		—		(10	)		—			(341	)		(351	)
Balance at April 2, 2022	$	1	$	1,174		$	(181	)	$	2,326		$	3,320

Balance at September 26, 2020	$	1	$	1,034		$	(551	)	$	1,608		$	2,092
Net income		—		—			—			311			311
Other comprehensive income		—		—			176			—			176
Share-based compensation		—		28			—			—			28
Proceeds from issuance of common stock		—		39			—			—			39
Balance at April 3, 2021	$	1	$	1,101		$	(375	)	$	1,919		$	2,646

See notes to consolidated financial statements.

Index

Berry Global Group, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

(in millions of dollars)

	Two Quarterly Periods Ended
	April 2, 2022			April 3, 2021
Cash Flows from Operating Activities:
Net income	$	326		$	311
Adjustments to reconcile net cash from operating activities:
Depreciation		284			280
Amortization of intangibles		133			147
Non-cash interest expense		8			16
Deferred income tax		(43	)		(28	)
Share-based compensation expense		28			28
Other non-cash operating activities, net		(14	)		51
Changes in working capital		(714	)		(156	)
Changes in other assets and liabilities		(22	)		(11	)
Net cash from operating activities		(14	)		638

Cash Flows from Investing Activities:
Additions to property, plant and equipment, net		(367	)		(364	)
Divestiture of business		3			143
Net cash from investing activities		(364	)		(221	)

Cash Flows from Financing Activities:
Proceeds from long-term borrowings		244			2,316
Repayments on long-term borrowings		(9	)		(2,683	)
Proceeds from issuance of common stock		22			39
Repurchase of common stock		(351	)		—
Debt financing costs		—			(16	)
Net cash from financing activities		(94	)		(344	)
Effect of currency translation on cash		3			20
Net change in cash and cash equivalents		(469	)		93
Cash and cash equivalents at beginning of period		1,091			750
Cash and cash equivalents at end of period	$	622		$	843

See notes to consolidated financial statements.

Index

Berry Global Group, Inc.

Notes to Consolidated Financial Statements

(Unaudited)

(tables in millions of dollars, except per share data)

1. Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. (“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. The Company’s U.S. based results for fiscal 2022 and fiscal 2021 are based on a fifty-two and fifty-three week period, respectively. The extra week in fiscal 2021 occurred in the first quarter. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated. For further information, refer to the Company’s most recent Form 10-K filed with the Securities and Exchange Commission.

2. Recent Accounting Pronouncements

Reference Rate Reform

In 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848). This standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR. ASU 2020-04 is effective upon issuance and generally can be applied through the end of calendar year 2022. The Company is currently evaluating the impact and whether it plans to adopt the optional expedients and exceptions provided under this new standard.

3. Revenue and Accounts Receivable

Our revenues are primarily derived from the sale of non-woven, flexible and rigid products to customers. Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration to which the Company expects to be entitled. We consider the promise to transfer products to be our sole performance obligation. If the consideration agreed to in a contract includes a variable amount, we estimate the amount of consideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method. Our main source of variable consideration is customer rebates. There are no material instances where variable consideration is constrained and not recorded at the initial time of sale. Generally, our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer. The accrual for customer rebates was $101 million and $104 million at April 2, 2022 and October 2, 2021, respectively, and is included in Other current liabilities on the Consolidated Balance Sheets. The Company disaggregates revenue based on reportable business segment, geography, and significant product line. Refer to Note 10. Segment and Geographic Data for further information.

Accounts receivable are presented net of allowance for credit losses of $19million and $21 million at April 2, 2022 and October 2, 2021, respectively. The Company records its current expected credit losses based on a variety of factors including historical loss experience and current customer financial condition. The changes to our current expected credit losses, write-off activity, and recoveries were not material for any of the periods presented.

The Company has entered into various factoring agreements, including customer-based supply chain financing programs, to sell certain receivables to third-party financial institutions. Agreements which result in true sales of the transferred receivables, which occur when receivables are transferred without recourse to the Company, are reflected as a reduction of accounts receivable on the consolidated balance sheets and the proceeds are included in the cash flows from operating activities in the consolidated statements of cash flows. The fees associated with the transfer of receivables for all programs were not material for any of the periods presented.

Index

4. Disposition

During fiscal 2022, the Company reached an initial agreement to sell our roto molding business which is operated in the Consumer Packaging International segment for expected proceeds of $114 million, which is preliminary and subject to adjustment at closing. The Company reported fiscal 2021 net sales of $146 million related to the business. For the period ended April 2, 2022, the Company classified assets of $156 million and liabilities of $49 million as held for sale. The assets and liabilities held for sale are recorded in Prepaid expenses and other current assets, and Other current liabilities, respectively, on the Consolidated Balance Sheets.

5. Restructuring and Transaction Activities

The table below includes the significant components of restructuring and transaction activities, by reporting segment:

	Quarterly Period Ended				Two Quarterly Periods Ended
	April 2, 2022		April 3, 2021		April 2, 2022			April 3, 2021
Consumer Packaging International	$	5	$	38	$	7		$	41
Consumer Packaging North America		2		—		3			1
Health, Hygiene & Specialties		—		—		(1	)		—
Engineered Materials		1		—		2			(5	)
Consolidated	$	8	$	38	$	11		$	37

The table below sets forth the activity with respect to the restructuring and transaction activities accrual at April 2, 2022:

	Restructuring
	Employee Severance and Benefits			Facility Exit Costs			Transaction Activities			Total
Balance as of October 2, 2021	$	6		$	5		$	—		$	11
Charges		3			6			2			11
Cash		(3	)		(7	)		(2	)		(12	)
Balance as of April 2, 2022	$	6		$	4		$	—		$	10

6. Leases

The Company leases certain manufacturing facilities, warehouses, office space, manufacturing equipment, office equipment, and automobiles.

We recognize right-of-use assets and lease liabilities for leases with original lease terms greater than one year based on the present value of lease payments over the lease term using our incremental borrowing rate on a collateralized basis. Short-term leases, with original lease terms of less than one year, are not recognized on the balance sheet. We are party to certain leases, namely for manufacturing facilities, which offer renewal options to extend the original lease term. Renewal options are included in the right-of-use asset and lease liability based on our assessment of the probability that the options will be exercised.

Supplemental lease information is as follows:

Leases	Classification	April 2, 2022		October 2, 2021
Operating leases:
Operating lease right-of-use assets	Right-of-use assets	$	536	$	562
Current operating lease liabilities	Other current liabilities		110		113
Noncurrent operating lease liabilities	Operating lease liability		443		466
Finance leases:
Finance lease right-of-use assets	Property, plant, and equipment, net	$	47	$	57
Current finance lease liability	Current portion of long-term debt		13		14
Noncurrent finance lease liabilities	Long-term debt, less current portion		30		38

Index

			Two Quarterly Periods Ended
Lease Type	Cash Flow Classification	Lease Expense Category	April 2, 2022		April 3, 2021
Operating	Operating	Lease cost	$	62	$	57
Finance	Operating	Interest expense		1		1
Finance	Financing	-		9		16
Finance	-	Amortization of right-of-use assets		5		7

Right-of-use assets obtained in exchange for new operating lease liabilities were $9 million and $21 million for the quarterly and two quarterly periods ended April 2, 2022, respectively.

7. Long-Term Debt

Long-term debt consists of the following:

Facility	Maturity Date	April 2, 2022			October 2, 2021
Term loan	July 2026	$	3,440			3,440
Revolving line of credit	May 2024		244			—
0.95% First Priority Senior Secured Notes	February 2024		800			800
1.00% First Priority Senior Secured Notes ^(a)	July 2025		776			810
1.57% First Priority Senior Secured Notes	January 2026		1,525			1,525
4.875% First Priority Senior Secured Notes	July 2026		1,250			1,250
1.65% First Priority Senior Secured Notes	January 2027		400			400
1.50% First Priority Senior Secured Notes ^(a)	July 2027		416			434
4.50% Second Priority Senior Secured Notes	February 2026		300			300
5.625% Second Priority Senior Secured Notes	July 2027		500			500
Debt discounts and deferred fees			(69	)		(77	)
Finance leases and other	Various		64			78
Total long-term debt			9,646			9,460
Current portion of long-term debt			(19	)		(21	)
Long-term debt, less current portion		$	9,627			9,439

^(a)	Euro denominated

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net on the Consolidated Statements of Income through maturity.

8. Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes.

Cross-Currency Swaps

The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk. The swap agreements mature May 2022 (€250 million), June 2024 (€1,625 million) and July 2027 (£700 million). In addition to cross-currency swaps, we hedge a portion of our foreign currency risk by designating foreign currency denominated long-term debt as net investment hedges of certain foreign operations. As of April 2, 2022, we had outstanding long-term debt of €785 million that was designated as a hedge of our net investment in certain euro-denominated foreign subsidiaries. When valuing cross-currency swaps the Company utilizes Level 2 inputs (substantially observable).

Index

Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt. When valuing interest rate swaps the Company utilizes Level 2 inputs (substantially observable).

As of April 2, 2022, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.398%, with an expiration in June 2026, (ii) a $400 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.916% with an expiration in June 2026, (iii) a $884 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 1.857%, with an expiration in June 2024, and (iv) a $473 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.050%, with an expiration in June 2024.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:

Derivative Instruments	Hedge Designation	Balance Sheet Location	April 2, 2022		October 2, 2021
Cross-currency swaps	Designated	Other long-term liabilities	$	222	$	323
Interest rate swaps	Designated	Other assets		45		—
Interest rate swaps	Designated	Other long-term liabilities		—		82
Interest rate swaps	Not designated	Other assets		26		—
Interest rate swaps	Not designated	Other long-term liabilities		68		49

The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended						Two Quarterly Periods Ended
Derivative Instruments	Statements of Income Location	April 2, 2022			April 3, 2021			April 2, 2022			April 3, 2021
Cross-currency swaps	Interest expense	$	(4	)	$	(1	)	$	(7	)	$	(4	)
Interest rate swaps	Interest expense		12			17			24			34

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2021 assessment. No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of April 2, 2022 and October 2, 2021, along with the impairment loss recognized on the fair value measurement during the period:

	As of April 2, 2022
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		5,091		5,091		—
Definite lived intangible assets		—		—		1,844		1,844		—
Property, plant, and equipment		—		—		4,650		4,650		—
Total	$	—	$	—	$	11,833	$	11,833	$	—

Index

	As of October 2, 2021
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		5,192		5,192		—
Definite lived intangible assets		—		—		1,994		1,994		—
Property, plant, and equipment		—		—		4,677		4,677		1
Total	$	—	$	—	$	12,111	$	12,111	$	1

The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and finance lease obligations. The book value of our marketable long-term indebtedness exceeded fair value by $212 million as of April 2, 2022. The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable).

9. Income Taxes

In comparison to the statutory rate, the higher effective tax rate for the quarter was negatively impacted by state taxes and global intangible low-taxed income provisions, partially offset by other discrete items.

10. Segment and Geographic Data

The Company’s operations are organized into fourreporting segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Engineered Materials. The structure is designed to align us with our customers, provide optimal service, drive future growth, and to facilitate synergies realization.

Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended				Two Quarterly Periods Ended
	April 2, 2022		April 3, 2021		April 2, 2022		April 3, 2021
Net sales:
Consumer Packaging International	$	1,139	$	1,060	$	2,195	$	2,048
Consumer Packaging North America		880		731		1,732		1,417
Health, Hygiene & Specialties		822		781		1,640		1,521
Engineered Materials		934		798		1,781		1,520
Total net sales	$	3,775	$	3,370	$	7,348	$	6,506
Operating income:
Consumer Packaging International	$	97	$	59	$	166	$	135
Consumer Packaging North America		85		77		131		136
Health, Hygiene & Specialties		69		114		131		210
Engineered Materials		90		83		142		156
Total operating income	$	341	$	333	$	570	$	637
Depreciation and amortization:
Consumer Packaging International	$	82	$	87	$	164	$	171
Consumer Packaging North America		53		54		107		110
Health, Hygiene & Specialties		44		42		89		87
Engineered Materials		27		29		57		59
Total depreciation and amortization	$	206	$	212	$	417	$	427

Index

Selected information by geographical region is presented in the following tables:

	Quarterly Period Ended				Two Quarterly Periods Ended
	April 2, 2022		April 3, 2021		April 2, 2022		April 3, 2021
Net sales:
United States and Canada	$	1,996	$	1,728	$	3,948	$	3,405
Europe		1,399		1,257		2,616		2,350
Rest of world		380		385		784		751
Total net sales	$	3,775	$	3,370	$	7,348	$	6,506

11. Contingencies and Commitments

The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company’s legal and financial liability with respect to such proceedings cannot be estimated with certainty, we believe that any ultimate liability would not be material to our financial statements.

The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

12. Share Repurchase Program

During the quarterly period ended April 2, 2022, the Company repurchased and retired 5,029 thousand shares for $300 million. For the two quarterly periods ended April 2, 2022, the Company repurchased and retired 5,756 thousand shares for $351 million. Authorized share repurchases of $700 million remain available to the Company.

13. Basic and Diluted Earnings Per Share

Basic net income or earnings per share ("EPS") is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted EPS includes the effects of options and restricted stock units, if dilutive.

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted EPS calculations:

	Quarterly Period Ended				Two Quarterly Periods Ended
(in millions, except per share amounts)	April 2, 2022		April 3, 2021		April 2, 2022		April 3, 2021
Numerator
Consolidated net income	$	205	$	181	$	326	$	311
Denominator
Weighted average common shares outstanding - basic		133.8		134.3		134.6		133.9
Dilutive shares		3.1		2.5		3.4		2.7
Weighted average common and common equivalent shares outstanding - diluted		136.9		136.8		138.0		136.6

Per common share earnings
Basic	$	1.53	$	1.35	$	2.42	$	2.32
Diluted	$	1.50	$	1.32	$	2.36	$	2.28

1.2 million and 1.3 million shares, respectively, were excluded from the diluted EPS calculation for the quarterly and two quarterly periods ended April 2, 2022 as their effect would be anti-dilutive. For the two quarterly periods ended April 3, 2021, 3.2 million shares were excluded.

Index

14. Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

Quarterly Period Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Derivative Instruments			Accumulated Other Comprehensive Loss
Balance at January 1, 2022	$	(176	)	$	(67	)	$	(46	)	$	(289	)
Other comprehensive income before reclassifications		37			—			69			106
Net amount reclassified		—			—			2			2
Balance at April 2, 2022	$	(139	)	$	(67	)	$	25		$	(181	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Derivative Instruments			Accumulated Other Comprehensive Loss
Balance at January 2, 2021	$	(100	)	$	(116	)	$	(140	)	$	(356	)
Other comprehensive income (loss) before reclassifications		(73	)		—			52			(21	)
Net amount reclassified		—			—			2			2
Balance at April 3, 2021	$	(173	)	$	(116	)	$	(86	)	$	(375	)

Two Quarterly Periods Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Derivative Instruments			Accumulated Other Comprehensive Loss
Balance at October 2, 2021	$	(154	)	$	(67	)	$	(75	)	$	(296	)
Other comprehensive income before reclassifications		15			—			95			110
Net amount reclassified		—			—			5			5
Balance at April 2, 2022	$	(139	)	$	(67	)	$	25		$	(181	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Derivative Instruments			Accumulated Other Comprehensive Loss
Balance at September 26, 2020	$	(278	)	$	(116	)	$	(157	)	$	(551	)
Other comprehensive income before reclassifications		105			—			67			172
Net amount reclassified		—			—			4			4
Balance at April 3, 2021	$	(173	)	$	(116	)	$	(86	)	$	(375	)

Index

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Executive Summary

Business. The Company’s operations are organized into four operating segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Engineered Materials. The structure is designed to align us with our customers, provide improved service, drive future growth, and to facilitate synergies realization. The Consumer Packaging International segment primarily consists of containers, closures and dispensing systems, pharmaceutical devices and packaging, bottles and canisters, and technical components. The Consumer Packaging North America segment primarily consists of containers and pails, foodservice, closures, overcaps, bottles, prescription vials, and tubes. The Health, Hygiene & Specialties segment primarily consists of nonwoven specialty materials, tapes and adhesives, and films used in hygiene, infection prevention, personal care, industrial, construction, and filtration applications. The Engineered Materials segment primarily consists of stretch and shrink films, converter films, institutional can liners, food and consumer films, retail bags, and agriculture films.

Raw Material Trends. Our primary raw material is polymer resin. In addition, we use other materials such as butyl rubber, adhesives, paper and packaging materials, linerboard, rayon, polyester fiber, and foil, in various manufacturing processes. While temporary industry-wide shortages of raw materials have occurred, we have historically been able to manage the supply chain disruption by working closely with our suppliers and customers. Supply shortages can lead to increased raw material price volatility, which we have experienced in recent quarters. Increases in the price of raw materials are generally able to be passed on to customers through contractual price mechanisms over time and other means. We expect supply chain challenges to continue throughout fiscal 2022 and will continue to work closely with our suppliers and customers in an effort to minimize any impact.

Outlook. The Company is affected by general economic and industrial growth, raw material availability, cost inflation, supply chain disruptions, and general industrial production. The COVID-19 pandemic has resulted in both advantaged and disadvantaged products within all segments. During fiscal 2022, we anticipate a headwind as the advantaged products, particularly in our Health, Hygiene & Specialties segment, related to the COVID-19 pandemic moderate while recovery of disadvantaged products lags with the ultimate impact being affected by both the duration certain products remain advantaged and timing of when disadvantaged products normalize. Our business has both geographic and end market diversity, which reduces the effect of any one of these factors on our overall performance. Our results are affected by our ability to pass through raw material and other cost changes to our customers, improve manufacturing productivity and adapt to volume changes of our customers. We believe that by providing advantaged products in targeted markets, our underlying long-term demand fundamental in all divisions will remain strong as we focus on delivering protective solutions that enhance consumer safety and execute on the Company’s mission statement of “Always Advancing to Protect What’s Important.” For fiscal 2022, we project cash flow from operations between $1.75 billion and $1.65 billion, which assumes the benefit from the lag in recovery of inflation, improved supply chains, and free cash flow between $1 billion and $900 million. Projected fiscal 2022 free cash flow assumes $750 million of capital spending. In addition, we repurchased 5,756 thousand shares for $351 million in the first half of the fiscal year and expect to continue repurchases in the second half of the fiscal year if current valuations persist. For the calculation of free cash flow and further information related to free cash flow as a non-GAAP financial measure, see “Liquidity and Capital Resources.”

Index

Results of Operations

Comparison of the Quarterly Period Ended April 2, 2022 (the “Quarter”) and the Quarterly Period Ended April 3, 2021 (the “Prior Quarter”)

Business integration expenses consist of restructuring and impairment charges, divestiture related costs, and other business optimization costs. Tables present dollars in millions.

Consolidated Overview
	Quarter		Prior Quarter		$ Change			% Change
Net sales	$	3,775	$	3,370	$	405			12	%
Cost of goods sold		3,154		2,706		448			17	%
Other operating expenses		280		331		(51	)		(15	)%
Operating income	$	341	$	333	$	8			2	%

Net Sales: The net sales growth is primarily attributed to increased selling prices of $576 million due to the pass through of inflation. This increase was partially offset by an organic volume decline of 2%, a $64 million unfavorable impact from foreign currency changes, extra shipping days in the Prior Quarter of $19 million, and Prior Quarter divestiture sales of $14 million. The volume decline is primarily attributed to supply chain disruptions and the moderation of advantaged products related to the COVID-19 pandemic.

Cost of goods sold: The cost of goods sold increase is attributed to inflation, partially offset by the volume decline, a decrease from foreign currency changes, extra shipping days in the Prior Quarter, and Prior Quarter divestiture cost of goods sold of $12 million.

Other operating expenses: The other operating expenses decrease is primarily attributed to a decrease in business integration expense and selling, general, and administrative expense.

Operating Income: The operating income increase is primarily attributed to a $37 million decrease in business integration expense, and a decrease in selling, general, and administrative expenses, partially offset by a $13 million unfavorable impact from price cost spread and negative product mix, a $12 million unfavorable impact from foreign currency, and a $10 million unfavorable impact from the volume decline.

Consumer Packaging International
	Quarter		Prior Quarter		$ Change		% Change
Net sales	$	1,139	$	1,060	$	79		7	%
Operating income	$	97	$	59	$	38		64	%

Net Sales: The net sales growth in the Consumer Packaging International segment is primarily attributed to increased selling prices of $144 million due to the pass through of inflation, partially offset by a $51 million unfavorable impact from foreign currency changes and Prior Quarter divestiture sales of $14 million.

Operating Income: The operating income increase is primarily attributed to a $39 million decrease in business integration expense and a $4 million decrease in amortization expense, partially offset by a $9 million unfavorable impact from foreign currency.

Consumer Packaging North America
	Quarter		Prior Quarter		$ Change		% Change
Net sales	$	880	$	731	$	149		20	%
Operating income	$	85	$	77	$	8		10	%

Net Sales: The net sales growth in the Consumer Packaging North America segment is primarily attributed to increased selling prices of $155 million due to the pass through of inflation.

Operating Income: The operating income increase is primarily attributed to an $11 million favorable impact from price cost spread.

Index

Health, Hygiene & Specialties
	Quarter		Prior Quarter		$ Change			% Change
Net sales	$	822	$	781	$	41			5	%
Operating income	$	69	$	114	$	(45	)		(39	)%

Net Sales: The net sales growth in the Health, Hygiene & Specialties segment is primarily attributed to increased selling prices of $82 million due to the pass through of inflation, partially offset by a 3% volume decline, and a $10 million unfavorable impact from foreign currency changes. The volume decline is primarily attributed to the moderation of advantaged products related to the COVID-19 pandemic.

Operating Income: The operating income decrease is primarily attributed to a $39 million unfavorable impact from price cost spread and negative product mix.

Engineered Materials
	Quarter		Prior Quarter		$ Change		% Change
Net sales	$	934	$	798	$	136		17	%
Operating income	$	90	$	83	$	7		8	%

Net Sales: The net sales growth in the Engineered Materials segment is primarily attributed to increased selling prices of $195 million due to the pass through of inflation, partially offset by a volume decline of 6%. The volume decline is primarily attributed to supply chain disruptions.

Operating Income: The operating income increase is primarily attributed to a $13 million favorable impact from price cost spread, partially offset by the unfavorable impact from the volume decline.

Other expense, net
	Quarter		Prior Quarter		$ Change		% Change
Other expense, net	$	6	$	6	$	—		—

The other expense in the Quarter is primarily attributed to a loss on asset disposals. The Prior Quarter expense is primarily attributed to debt extinguishment costs, partially offset by favorable foreign currency changes related to the remeasurement of non-operating intercompany balances.

Interest expense, net
	Quarter		Prior Quarter		$ Change			% Change
Interest expense, net	$	71	$	84	$	(13	)		(15	)%

The interest expense decrease is primarily the result of refinancing activities and repayment of borrowings in fiscal 2021.

Changes in Comprehensive Income

The $151 million improvement in comprehensive income from the Prior Quarter is primarily attributed to a $24 million improvement in net income, a $17 million favorable change in the fair value of derivative instruments, net of tax, and a $110 million favorable change in currency translation. Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates. The change in currency translation in the YTD was primarily attributed to locations utilizing the euro, British pound sterling, Brazilian real, Canadian dollar, Chinese renminbi and Mexican peso as the functional currency. As part of the overall risk management, the Company uses derivative instruments to (i) reduce our exposure to changes in interest rates attributed to the Company’s borrowings and (ii) reduce foreign currency exposure to translation of certain foreign operations. The Company records changes to the fair value of these instruments in Accumulated other comprehensive loss. The change in fair value of these instruments in fiscal 2022 versus fiscal 2021 is primarily attributed to the change in the forward interest and foreign exchange curves between measurement dates.

Index

Comparison of the Two Quarterly Periods Ended April 2, 2022 (the “YTD”) and the Two Quarterly Periods Ended April 3, 2021 (the “Prior YTD”)

The Company’s U.S. based results for the YTD and Prior YTD are based on a twenty-six and twenty-seven week period, respectively. Business integration expenses consist of restructuring and impairment charges, divestiture related costs, and other business optimization costs. Tables present dollars in millions.

Consolidated Overview
	YTD		Prior YTD		$ Change			% Change
Net sales	$	7,348	$	6,506	$	842			13	%
Cost of goods sold		6,192		5,224		968			19	%
Other operating expenses		586		645		(59	)		(9	)%
Operating income	$	570	$	637	$	(67	)		(11	)%

Net Sales: The net sales growth is primarily attributed to increased selling prices of $1.3 billion due to the pass through of inflation. This increase was partially offset by an organic volume decline of 3%, extra days in the Prior YTD of $131 million, an $81 million unfavorable impact from foreign currency changes, and Prior YTD divestiture sales of $62 million. The volume decline is primarily attributed to supply chain disruptions and the moderation of advantaged products related to the COVID-19 pandemic.

Cost of goods sold: The cost of goods sold increase is attributed to inflation, partially offset by the volume decline, a decrease from foreign currency changes, extra days in the Prior YTD, and Prior YTD divestiture cost of goods sold of $50 million.

Other operating expenses: The other operating expenses decrease is primarily attributed to a decrease in business integration expense, selling, general, and administrative expense, and amortization expense.

Operating Income: The operating income decrease is primarily attributed to a $54 million unfavorable impact from price cost spread, a $25 million unfavorable impact from the volume decline, a $22 million decrease from extra shipping days in the Prior YTD, a $15 million unfavorable impact from foreign currency, and a negative impact from Prior YTD divestiture operating income, partially offset by a $46 million decrease in business integration expense, and a decrease in selling, general, and administrative expenses.

Consumer Packaging International
	YTD		Prior YTD		$ Change		% Change
Net sales	$	2,195	$	2,048	$	147		7	%
Operating income	$	166	$	135	$	31		23	%

Net Sales: The net sales growth in the Consumer Packaging International segment is primarily attributed to increased selling prices of $260 million due to the pass through of inflation, partially offset by a $67 million unfavorable impact from foreign currency changes and Prior YTD divestiture sales of $28 million.

Operating Income: The operating income increase is primarily attributed to a $47 million decrease in business integration expense and a decrease in depreciation and amortization expense, partially offset by an $11 million unfavorable impact from foreign currency and a $9 million unfavorable impact from price cost spread.

Consumer Packaging North America
	YTD		Prior YTD		$ Change			% Change
Net sales	$	1,732	$	1,417	$	315			22	%
Operating income	$	131	$	136	$	(5	)		(4	)%

Net Sales: The net sales growth in the Consumer Packaging North America segment is primarily attributed to increased selling prices of $371 million due to the pass through of inflation, partially offset by a $40 million decrease from extra shipping days in the Prior YTD.

Operating Income: The operating income decrease is primarily attributed to a $7 million decrease from extra shipping days in the Prior YTD.

Index

Health, Hygiene & Specialties
	YTD		Prior YTD		$ Change			% Change
Net sales	$	1,640	$	1,521	$	119			8	%
Operating income	$	131	$	210	$	(79	)		(38	)%

Net Sales: The net sales growth in the Health, Hygiene & Specialties segment is primarily attributed to increased selling prices of $225 million due to the pass through of inflation, partially offset by a 4% volume decline, and a $42 million decrease from extra shipping days in the Prior YTD. The volume decline is primarily attributed to supply chain disruptions and the moderation of advantaged products related to the COVID-19 pandemic.

Operating Income: The operating income decrease is primarily attributed to a $61 million unfavorable impact from price cost spread, an $11 million unfavorable impact from the volume decline, and an $8 million decrease from extra shipping days in the Prior YTD.

Engineered Materials
	YTD		Prior YTD		$ Change			% Change
Net sales	$	1,781	$	1,520	$	261			17	%
Operating income	$	142	$	156	$	(14	)		(9	)%

Net Sales: The net sales growth in the Engineered Materials segment is primarily attributed to increased selling prices of $426 million due to the pass through of inflation, partially offset by a volume decline of 5%, a $44 million decrease from extra shipping days in the Prior YTD, and Prior YTD divestiture sales of $34 million. The volume decline is primarily attributed to supply chain disruptions.

Operating Income: The operating income decrease is primarily attributed to a $13 million impact from Prior YTD divestiture operating income, a $9 million unfavorable impact from the volume decline, and a decrease from extra shipping days in the Prior YTD, partially offset by a $13 million favorable impact from price cost spread.

Other expense
	YTD		Prior YTD		$ Change			% Change
Other expense	$	6	$	31	$	(25	)		(81	)%

The other expense decrease is primarily attributed to foreign currency changes related to the remeasurement of non-operating intercompany balances in the Prior YTD.

Interest expense
	YTD		Prior YTD		$ Change			% Change
Interest expense	$	142	$	181	$	(39	)		(22	)%

The interest expense decrease is primarily the result of refinancing activities and repayments of borrowings in fiscal 2021.

Changes in Comprehensive Income

The $46 million decline in comprehensive income from the Prior YTD was primarily attributed to a $15 million improvement in net income, a $90 million unfavorable change in currency translation, and a $29 million favorable change in the fair value of derivative instruments, net of tax. Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates. The change in currency translation in the YTD was primarily attributed to locations utilizing the euro, British pound sterling, Brazilian real, Canadian dollar, Chinese renminbi and Mexican peso as the functional currency. As part of the overall risk management, the Company uses derivative instruments to (i) reduce our exposure to changes in interest rates attributed to the Company’s borrowings and (ii) reduce foreign currency exposure to translation of certain foreign operations. The Company records changes to the fair value of these instruments in Accumulated other comprehensive loss. The change in fair value of these instruments in fiscal 2022 versus fiscal 2021 is primarily attributed to the change in the forward interest and foreign exchange curves between measurement dates.

Index

Liquidity and Capital Resources

Senior Secured Credit Facility

We manage our global cash requirements considering (i) available funds among the many subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances. At the end of the Quarter, the Company had an outstanding balance of $244 million on its $950 million asset-based revolving line of credit that matures in May 2024. The Company was in compliance with all covenants at the end of the Quarter.

Cash Flows

Net cash from operating activities decreased $652 million from the Prior YTD primarily attributed to working capital inflation and timing of payables.

Net cash used in investing activities increased $143 million from the Prior YTD primarily attributed to fewer proceeds from business divestiture.

Net cash used in financing activities decreased $250 million from the Prior YTD primarily attributed to higher net borrowings, partially offset by repurchases of common stock in the YTD.

Share Repurchases

During fiscal 2022, the Company repurchased 5.8 million shares for $351 million. Authorized share repurchases of $700 million remain available to the Company.

Free Cash Flow

Our consolidated free cash flow for the YTD and Fiscal 2022 Outlook are summarized as follows:

	April 2, 2022			Fiscal 2022 Outlook
Cash flow from operating activities	$	(14	)	$	1,650-1,750
Additions to property, plant and equipment, net		(367	)		(750	)
Free cash flow	$	(381	)	$	900-1,000

We use free cash flow as a supplemental measure of liquidity as it assists us in assessing our ability to fund growth through generation of cash. Free cash flow may be calculated differently by other companies, including other companies in our industry or peer group, limiting its usefulness on a comparative basis. Free cash flow is not a financial measure presented in accordance with generally accepted accounting principles ("GAAP") and should not be considered as an alternative to any other measure determined in accordance with GAAP.

Liquidity Outlook

At April 2, 2022, our cash balance was $622 million, which was primarily located outside the U.S. We believe our existing U.S. based cash and cash flow from U.S. operations, together with available borrowings under our senior secured credit facilities, will be adequate to meet our short-term and long-term liquidity needs with the exception of funds needed to cover all long-term debt obligations, which we intend to refinance prior to maturity. The Company has the ability to repatriate the cash located outside the U.S. to the extent not needed to meet operational and capital needs without significant restrictions.

Index

Summarized Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this section, “Parent”) and substantially all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of Issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility.

Presented below is summarized financial information for the Parent, Issuer and guarantor subsidiaries on a combined basis, after intercompany transactions have been eliminated.

	Two Quarterly Periods Ended
	April 2, 2022
Net sales	$	3,813
Gross profit		599
Earnings from continuing operations		175
Net income	$	175

Includes $2 million of income associated with intercompany activity with non-guarantor subsidiaries.

	April 2, 2022		October 2, 2021
Assets
Current assets	$	2,033	$	2,293
Noncurrent assets		6,044		5,979

Liabilities
Current liabilities	$	1,094	$	1,533
Intercompany payable		634		629
Noncurrent liabilities		11,097		11,083

Index

Item 3. Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

We are exposed to market risk from changes in interest rates primarily through our senior secured credit facilities. Our senior secured credit facilities are comprised of (i) $3.4 billion term loans and (ii) a $950 million revolving credit facility with $244 million outstanding. Borrowings under our senior secured credit facilities bear interest at a rate equal to an applicable margin plus LIBOR. The applicable margin for LIBOR rate borrowings under the revolving credit facility ranges from 1.25% to 1.50%, and the margin for term loans is 1.75% per annum. As of period end, the LIBOR rate of approximately 0.46% was applicable to the term loans. A 0.25% change in LIBOR would increase our annual interest expense by $3 million on variable rate term loans.

We seek to minimize interest rate volatility risk through regular operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments. These financial instruments are not used for trading or other speculative purposes. (See Note 8.)

Foreign Currency Risk

As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates, primarily the U.S. dollar against the euro, British pound sterling, Brazilian real, Chinese renminbi, Canadian dollar and Mexican peso. Significant fluctuations in currency rates can have a substantial impact, either positive or negative, on our revenue, cost of sales, and operating expenses. Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates and impact our Comprehensive income. A 10% decline in foreign currency exchange rates would have had a $6 million unfavorable impact on our Net income for the two quarterly periods ended April 2, 2022. (See Note 8.)

Index

Item 4. Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Under applicable Securities and Exchange Commission regulations, management of a reporting company, with the participation of the principal executive officer and principal financial officer, must periodically evaluate the company’s “disclosure controls and procedures,” which are defined generally as controls and other procedures of a reporting company designed to ensure that information required to be disclosed by the reporting company in its periodic reports filed with the commission (such as this Form 10-Q) is recorded, processed, summarized, and reported on a timely basis.

The Company’s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this report.

(b) Changes in internal control over financial reporting.

There were no changes in our internal control over financial reporting that occurred during the Quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Index

Part II. Other Information

Item 1. Legal Proceedings

There have been no material changes in legal proceedings from the items disclosed in our Form 10-K filed with the Securities and Exchange Commission.

Item 1A. Risk Factors

On February 24, 2022, Russia launched an invasion of Ukraine which has resulted in increased volatility in various sectors and markets. The extent and duration of the military action, resulting sanctions and future market disruptions in the region are not currently known. While the Company’s sales and assets in Russia are immaterial, the effects of the hostilities and sanctions may spill over to our customers and negatively impact their operations. Additionally, the ongoing military action along with the potential for a wider conflict could further increase market volatility and cause negative effects on regional and global economic markets, industries, and companies.

Before investing in our securities, we recommend that investors carefully consider the risks described in our most recent Form 10-K filed with the Securities and Exchange Commission, including those under the heading “Risk Factors” and other information contained in this Quarterly Report. Realization of any of these risks could have a material adverse effect on our business, financial condition, cash flows and results of operations.

Additionally, we caution readers that the list of risk factors discussed in our most recent Form 10-K may not contain all of the material factors that are important to you. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this report may not in fact occur. Accordingly, readers should not place undue reliance on those statements.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Repurchases of Equity Securities

The following table summarizes the Company's repurchases of its common stock during the Quarterly Period ended April 2, 2022.

Fiscal Period	Total Number of Shares Purchased		Average Price Paid Per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs		Dollar Value of Shares that May Yet be Purchased Under the Program (in millions) ^(a)
January		164,100	$	61.75		164,100	$	990
February		2,405,334		61.16		2,405,334		843
March		2,459,076		58.05		2,459,076		700
Total		5,028,510	$	59.66		5,028,510	$	700

(a)	All open market purchases during the quarter were made under the fiscal 2022 authorization from our board of directors to purchase up to $1 billion of shares of common stock. (See Note 12.)

Index

Item 6. Exhibits

Exhibit No.		Description of Exhibit
22.1*		Subsidiary Guarantors
31.1*		Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
31.2*		Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
32.1**		Section 1350 Certification of the Chief Executive Officer.
32.2**		Section 1350 Certification of the Chief Financial Officer.
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith

**	Furnished herewith

Index

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	Berry Global Group, Inc.

May 5, 2022	By:	/s/ Mark W. Miles
		Mark W. Miles
		Chief Financial Officer

Berry Global - 10-Q quarterly report FY2022 Q2

What is the market capitalization of a company?

DISCLAIMER

Contact

Links